Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today ann ...

Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Types of dermatitis Dermatitis encompasses various types, each with unique characteristics. Atopic Dermatitis, commonly known as eczema, manifests as chronic, itchy, and inflamed skin persisting from ...

Nektar continues to make progress with rezpegaldesleukin, with results from phase 2 atopic dermatitis study expected in H1'25 ...

Two studies assessed the quality and accuracy of ChatGPT recommendations for atopic dermatitis based on their concordance with clinical guidelines.

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the publication of a case study highlighting the use of ...

Removing zelnecirnon means the biotech’s sole remaining clinical-stage asset is tivumecirnon, a phase 2 oncology med being ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...

While we may explore this potential in the future or via partnerships, we are currently focused on enrolling our soquelitinib registration Phase 3 trial in peripheral T cell lymphoma and Phase 1 trial ...